Rapamycin, primarily known for preventing organ transplant rejection, shows promise in enhancing the function of aging organs and tissues. Recent studies indicate that treatment can improve immune response and heart function in older subjects. The implications of these findings suggest a revolutionary approach to aging interventions, potentially reversing declines rather than merely slowing them.
